Posts Tagged ‘Spark Capital’

VCs testifying all over the place: Terry McGuire in DC on VC regulation, Bijan Sabet on Beacon Hill on non-competes

Wednesday, October 7th, 2009

Testimony of Terry Mcguire Final 10-6-09

Polaris partner Terry McGuire testified yesterday before chairman Barney Frank and the U.S. House Financial Services Committee. As chairman of the National Venture Capital Association, McGuire (testimony above) tried to persuade lawmakers to keep the venture capital industry from having to register with the SEC.

Closer to home, Spark Capital’s Bijan Sabet is scheduled to testify at the State House today against the use of non-compete As of about 1 pm, he hadn’t testified yet, but wasn’t alone in his opinion. After the jump, read Sabet’s written testimony. (more…)

NewsFlash Roundup: VistaPrint, Children’s Hospital, Ceradyne

Thursday, July 23rd, 2009

netsi072309Children’s Hospital helps out some mice who have had heart attacks, the former Diaphorm develops a new helmet for marines and Vistaprint gets bad news two times in today’s NewsFlash Roundup.  

Children’s Hospital research gets hearts growing new cells

The treatment could help heart attack victims or children with congenital heart defects, according to the hospital. In the July 24 issue of the journal Cell, the researchers show an injection of the growth factor neuregulin1 (NRG1) into an animal who has had a heart attack can stimulate heart muscle growth.

Former Diaphorm wins $1.2M for new Marine helmet

Defense contractor Ceradyne Inc. reports its Salem, N.H.-based unit has been awarded Marine Corps contracts worth approximately $1.2 million for new test helmets using advanced materials. 

Vistaprint slammed by IP lawsuit, bad analyst report

New Jersey-based ColorQuick LLC has filed a lawsuit alleging Vistaprint and OfficeMax Inc. (NYSE: OMX) have been illegally using a patented process for fast printing. Meanwhile, Citron Research issued a negative report on the company Tuesday, suggesting VistaPrint could lose 44 percent of its net income – the portion it derives from referral partnerships with third-party websites — as the U.S. Senate begins an inquiry into such online referral programs. (more…)

Spark Capital’s Next New Networks lays off 7

Thursday, July 16th, 2009

Next New Networks, a Spark Capital portfolio company, plans to lay off seven workers, according to PaidContent.org.   

The web video company, which produces comedy, fashion, celebrity gossip and other kinds of web-based TV shows, lost the political blog Talking Points Memo as a client last year.

At the beginning of the year, MHT wrote about the NYC-based media startups pulling VC dollars from New England firms like Flybridge and Spark.

Bostonist: What’s Next in Tech video

Monday, June 29th, 2009

What’s Next In Tech 2009 – The Venture Capitalist Panel from Thomas Attila Lewis on Vimeo.

Bostonist shot video of last week’s What’s Next in Tech event at Boston University, hosted by Scott Kirsner. Above, Flybridge’s Michael Greeley, Spark’s Bijan Sabet, and General Catalyst’s Neil Sequiera speak on a venture capital panel.

After the jump, watch Harmonix’ Mike Dornbrook, the Droid Works’ Helen Greiner, HubSpot’s Brian Halligan, EnerNOC’s Tim Healy and Ellen Rubin of CloudSwitch on an entrepreneurship panel. (more…)

Finance Roundup: Stimulus funds for Conn.; Dyax, Taris, AdMeld get funding

Thursday, June 25th, 2009

Almost $60 million dollars changes hands in today’s roundup of finance news from MHT:

• Conn. to receive $15.4M in alternative energy stimulus

The funding from the U.S. Department of Energy is about half of the state’s $38 million in stimulus funds for its State Energy Plan submitted to the federal government last month.
About $8 million will go to expanding fuel cell initiatives through the state Clean Energy fund, with the goal of completing 14 more projects. A rebate program for residential and commercial geothermal systems will receive $5 million. Two plans to support solar thermal and photovoltaic installations will receive $7 million.

• Dyax raises $15M in stock offering

Biotherapeutics company Dyax Corp. says it is raising $15 million through a follow-on offering of 7.4 million shares of its common stock at a price of $2.02 per share.

Dyax reports it intends to use the money raised in the offering to fund the development and commercialization of DX-88, the company’s treatment for the rare and often fatal condition hereditary angioedema. In addition, Dyax will use the cash to fund ongoing research and preclinical activities, as well as for general corporate purposes.

Finance Roundup: Vestmark, Axis Three, FlyClear.com

Tuesday, June 23rd, 2009

Vestmark nabs a million, Axis Three moves in, and FlyClear.com shuts down in today’s Finance Roundup.

Affiliate publications: ACBJ.com, Boston Business Journal, Bizjournals.com, Portfolio.com, Wired.com

Web Site Developed by Neptune Web, Inc.

Use of and/or registration on any portion of this site constitutes acceptance of our User Agreement and Privacy Policy. About our ads.